Nuveen
BIOA

Nuveen’s BioAge Labs BIOA Stock Holding History

Nuveen’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.56M Buy
349,142
+300,454
+617% +$5.43M ﹤0.01% 1796
2026
Q1 		$852K Buy
48,688
+17,894
+58% +$345K ﹤0.01% 2652
2025
Q4 		$407K Hold
30,794
– – ﹤0.01% 2952
2025
Q3 		$181K Hold
30,794
– – ﹤0.01% 3173
2025
Q2 		$127K Sell
30,794
-24,612
-44% -$99.2K ﹤0.01% 3235
2025
Q1 		$118K Buy
55,406
+39,958
+259% +$185K ﹤0.01% 3201
2024
Q4 		$89.4K Buy
+15,448
New +$266K ﹤0.01% 3296

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Nuveen's BIOA Position: Q2 2026 in Review

Nuveen increased its BioAge Labs (BIOA) stake by 617% in Q2 2026, buying an estimated $5.43M and bringing the position to 349,142 shares worth $8.56M. The position accounts for ﹤0.01% of the portfolio, ranked #1796.

Nuveen first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Nuveen held 349,142 shares of BioAge Labs worth $8.56M as of Q2 2026.
  • Nuveen bought 300,454 BioAge Labs shares in Q2 2026, an estimated $5.43M.
  • BioAge Labs made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1796 holding.
  • Nuveen first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.